# MERITAGE PHARMA INC: Form D filings

MERITAGE PHARMA INC, a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2009 and 2011. The latest, on November 16, 2011, reports $6.5 million sold of a $7.5 million offering to 10 investors.

Find out what MERITAGE PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MERITAGE%20PHARMA%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MERITAGE%20PHARMA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fmeritage-pharma-inc-1432016)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MERITAGE%20PHARMA%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MERITAGE%20PHARMA%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fmeritage-pharma-inc-1432016)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 12481 HIGH BLUFF DRIVE, SUITE 160, San Diego, CA, 92130
- Phone: (858) 436-1660
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2008
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1432016

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 16, 2011 | Amendment | $7,500,002 | $6,500,002 | $1,000,000 | 10 | Jan 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1432016/000143201611000002/0001432016-11-000002-index.htm) |
| Jan 27, 2011 | New notice | $5,500,001 | $2,000,001 | $3,500,000 | 10 | Jan 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1432016/000143201611000001/0001432016-11-000001-index.htm) |
| Aug 27, 2009 | Amendment | $29,972,053 | $29,972,053 | $0 | 23 | Aug 17, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1432016/000143201609000005/0001432016-09-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James C. Blair, Ph.D. | Director |  |
| Elaine M. Phillips, Ph.D. | Executive Officer, Director |  |
| Cam L. Garner | Director |  |
| Kenneth J. Widder, M.D. | Director |  |
| Malcolm R. Hill | Executive Officer |  |
| Adam K. Simpson | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Nov 14, 2011](https://specstream.ai/data/form-d/week/2011-11-14) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what MERITAGE PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).